NCT06862557

Pulsed Electromagnetic Field Treatment With Dementia Patients

Effects of PEMF Treatment on Patients With Mild to Moderate Dementia in a Controlled Pilot Study

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 48 (estimated)
• Sponsor: Herrick Medical LLC · Industry
• Sex: All
• Age: 50 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

An open label pilot study in mild to moderate AD/ADRD patients to assess the effects of treatment with ECHS AD/ADRD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end point is the The Alzheimer's Disease Assessment Scale-Cognitive Subscale. Participants will be followed-up for 9 months post-treatment.

Conditions

• Alzheimer's Disease
• Lewy Body Dementia
• Vascular Dementia

Interventions

Type	Name	Description
DEVICE	ECHS AD Device	Pulsed electromagnetic therapy device

Timeline

• Start date: 2025-04-01
• Primary completion: 2026-04-30
• Completion: 2026-09-30
• First posted: 2025-03-06
• Last updated: 2025-05-18

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study